Aktiesnakken — November 2010
-
tak hofpeung!
-
ny for mig...
-
Genmab ASH. Ser fornuftigt ud http://ash.confex.com/ash/2010/webprogram/Paper30354.html
-
ja orr på 63% er godt
-
-
det er så 2nd line, men giver sådan noget offlabel salg? Det kunne det vel godt?
-
63% det er sku et meget godt til patienten
-
tak igen Hofpeung.
-
fik sas ikke lige nået at dementere denne som et rygte inden de selvsamme dag så blev til den?
-
-
taler vi gen...det ser sku meget fornuftigt ud. Så Hrmunk må vel snart pakke sit spøgelse sammen eller hvad?
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind